DUBLIN, Ireland,
Feb. 14, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc
(NASDAQ:AVDL), today announced it will report its fourth
quarter and full year 2016 financial results on Tuesday,
March 7, 2017, before the market open. A conference call to
discuss these results has been scheduled for Tuesday, March
7, 2017 at 10:00 a.m. ET. A question and answer period will
follow management's prepared remarks.
To access the conference call, investors are invited to dial (844) 388-0559 (U.S. and Canada) or (216) 562-0393 (international). The conference ID number is 69283135. A live audio webcast and accompanying slides can be accessed by visiting the “News & Events” page of the Company’s Investors website at www.avadel.com. A replay of the webcast will be archived on Avadel’s website for 90 days following the event.
About
Avadel Pharmaceuticals plc:
Avadel Pharmaceuticals plc (NASDAQ:AVDL) is a specialty
pharmaceutical company that seeks to develop differentiated
pharmaceutical products that are safe, effective and easy to
take through formulation development, by utilizing its
proprietary drug delivery technology and in-licensing /
acquiring new products; ultimately, helping patients adhere
to their prescribed medical treatment and see better
results. Avadel currently markets products in the hospital
and primary care spaces. The Company is headquartered in
Dublin, Ireland with operations in St. Louis, Missouri and
Lyon, France. For more information, please visit www.avadel.com.
DUBLIN,
Ireland, Feb. 06, 2017 (GLOBE NEWSWIRE) -- Avadel
Pharmaceuticals plc (NASDAQ:AVDL), today announced that
management will present at two upcoming investor
conferences:
- LEERINK Partners 6th Annual
Global Healthcare Conference on Wednesday, February
15, 2017 at 9:00 a.m. Eastern Time in New York City
- RBC Capital Markets 2017 Global Healthcare Conference on Thursday, February 23, 2017 at 9:30 a.m. Eastern Time in New York City
A live audio webcast of both presentations can be accessed at the “News & Events” section of the Company’s website, www.avadel.com. A replay of these webcasts will be available for 90 days following the event.
About Avadel Pharmaceuticals plc:
Avadel Pharmaceuticals plc (NASDAQ:AVDL) is a specialty
pharmaceutical company that seeks to develop
differentiated pharmaceutical products that are safe,
effective and easy to take through formulation
development, by utilizing its proprietary drug delivery
technology and in-licensing / acquiring new products;
ultimately, helping patients adhere to their prescribed
medical treatment and see better results. Avadel
currently markets products in the hospital and primary
care spaces. The Company is headquartered in Dublin,
Ireland with operations in St. Louis, Missouri and Lyon,
France. For more information, please visit www.avadel.com.
Forward and Cautionary Statement - Disclaimer
About TopStockReporter.com :
TopStockReporter.com
, a subsidiary of Target Publishing Inc, and is a
leading publisher of todays market and investment news,
commentary, proprietary research and videos from
seasoned journalists, analysts and contributors covering
the financial markets and global economies. Leveraging
our extensive distribution network and social media
presence, we have cultivated
a valuable audience of
engaged market enthusiasts, which in turn
delivers a variety of unique opportunities for industry
partnerships, corporate communications, market exposure
and investment.
A complete disclaimer can be viewed HERE